Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia

L. Schweizer, Marin; P. Furuno, Jon; D. Harris, Anthony; Kristie Johnson, J.; Shardell, Michelle; C. McGregor, Jessina; A. Thom, Kerri; E. Cosgrove, Sara; Sakoulas, George; N. Perencevich, Eli

doi:10.1186/1471-2334-11-279

Public

Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia

Published in BMC Infectious Diseases • Oct 19, 2011

Authors:

Marin L. Schweizer

Jon P. Furuno

Anthony D. Harris

Abstract

BACKGROUND: The high prevalence of methicillin-resistant S. aureus (MRSA) has led clinicians to select antibiotics that have coverage against MRSA, usually vancomycin, for empiric therapy for suspected staphylococcal infections. Clinicians often continue vancomycin started empirically even when meth...

Subject

Nafcillin

Cefazolin

Vancomycin

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!